Excellent Results from the DESolve I First-In-Man Study at One Year for Fully Bioresorbable Drug Eluting Coronary Scaffold System Presented Sunnyvale, Calif. – Elixir Medical Corporation, a developer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results